We are live on
!
Find out more
JAG
Journey Advisory Group Portfolio holdings
AUM
$1.17B
1-Year Est. Return
20.21%
This Fund
S&P 500
This Quarter
Est. Return
+10.88%
1 Year Est. Return
+20.21%
3 Year Est. Return
+58.66%
5 Year Est. Return
+76.52%
10 Year Est. Return
–
AUM
$267M
AUM Growth
–
Cap. Flow
+$255M
Cap. Flow
% of AUM
95.31%
Top 10 Holdings %
Top 10 Hldgs %
34%
Holding
180
New
180
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$18.8M |
| 2 |
Procter & Gamble
PG
|
+$14.3M |
| 3 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$7.67M |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$7.65M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$6.84M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.42% |
| 2 | Healthcare | 9.86% |
| 3 | Consumer Staples | 9.42% |
| 4 | Financials | 7.39% |
| 5 | Industrials | 5.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
iShares Core S&P 500 ETF
IVV
$869B
| $2.77M | 1.04% |
+7,390
| New | +$2.63M |
|
27
Edwards Lifesciences
EW
$47.8B
| $2.69M | 1.01% |
+29,529
| New | +$2.45M |
|
28
Berkshire Hathaway Class B
BRK.B
$1.07T
| $2.62M | 0.98% |
+11,291
| New | +$2.49M |
|
29
Eli Lilly
LLY
$1.07T
| $2.6M | 0.97% |
+15,418
| New | +$2.3M |
|
30
Humana
HUM
$45.8B
| $2.52M | 0.94% |
+6,150
| New | +$2.56M |
|
31
US Bancorp
USB
$98.9B
| $2.26M | 0.85% |
+48,512
| New | +$2.05M |
|
32
iShares Biotechnology ETF
IBB
$9.44B
| $2.26M | 0.84% |
+14,895
| New | +$2.13M |
|
33
Invesco Preferred ETF
PGX
$3.81B
| $2.21M | 0.83% |
+145,083
| New | +$2.18M |
|
34
Chubb
CB
$139B
| $2.17M | 0.81% |
+14,094
| New | +$1.98M |
|
35
Duke Energy
DUK
$100B
| $2.11M | 0.79% |
+23,043
| New | +$2.13M |
|
36
Merck
MRK
$323B
| $2.09M | 0.78% |
+26,790
| New | +$2.05M |
|
37
Verizon
VZ
$198B
| $2.06M | 0.77% |
+35,041
| New | +$2.08M |
|
38
Pfizer
PFE
$141B
| $2.01M | 0.75% |
+54,668
| New | +$2.01M |
|
39
FedEx
FDX
$73.5B
| $2M | 0.75% |
+7,697
| New | +$2.13M |
|
40
CSX Corp
CSX
$96B
| $1.85M | 0.69% |
+61,011
| New | +$1.75M |
|
41
TJX Companies
TJX
$173B
| $1.84M | 0.69% |
+26,922
| New | +$1.64M |
|
|
42
Berkshire Hathaway Class A
BRK.A
$1.07T
| $1.74M | 0.65% |
+5
| New | +$1.65M |
|
43
Clorox
CLX
$11.8B
| $1.73M | 0.65% |
+8,549
| New | +$1.77M |
|
|
COR
44
DELISTED
Coresite Realty Corporation
COR
| $1.67M | 0.62% |
+13,313
| New | +$1.65M |
|
45
Northrop Grumman
NOC
$77.8B
| $1.66M | 0.62% |
+5,454
| New | +$1.67M |
|
46
Crown Castle
CCI
$32.4B
| $1.65M | 0.62% |
+10,331
| New | +$1.68M |
|
47
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
| $1.63M | 0.61% |
+19,528
| New | +$1.62M |
|
48
AbbVie
ABBV
$454B
| $1.6M | 0.6% |
+14,925
| New | +$1.43M |
|
49
3M
MMM
$91.9B
| $1.55M | 0.58% |
+10,603
| New | +$1.51M |
|
50
ExxonMobil
XOM
$642B
| $1.51M | 0.57% |
+36,719
| New | +$1.38M |
|
Similar funds
TFA
FG
BBCM
OA
MTC
PWAM
OCAI
OWSCM
Journey Advisory Group's Q4 2020 Portfolio in Review
Q4 2020 is the first quarter with a 13F filing on record for Journey Advisory Group, which disclosed 180 positions worth $267M. Its ten largest holdings account for 34% of the portfolio.
Its largest position is Apple: 156,456 shares worth $20.8M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, followed by Healthcare and Consumer Staples.
- Journey Advisory Group's largest Q4 2020 buy was Apple: 156,456 shares worth $20.8M.
- Journey Advisory Group's ten largest holdings make up 34% of its $267M portfolio in Q4 2020.
- Journey Advisory Group disclosed 180 positions in Q4 2020, its first 13F filing on record.
Based on Journey Advisory Group's 13F filing for Q4 2020, filed 19 Jan 2021.